265 related articles for article (PubMed ID: 25716055)
1. Cardiac lesions and initial laboratory data in Kawasaki disease: a nationwide survey in Japan.
Kuwabara M; Yashiro M; Kotani K; Tsuboi S; Ae R; Nakamura Y; Yanagawa H; Kawasaki T
J Epidemiol; 2015; 25(3):189-93. PubMed ID: 25716055
[TBL] [Abstract][Full Text] [Related]
2. Difference in Risk Factors for Subtypes of Acute Cardiac Lesions Resulting from Kawasaki Disease.
Yamashita M; Ae R; Yashiro M; Aoyama Y; Sano T; Makino N; Nakamura Y
Pediatr Cardiol; 2017 Feb; 38(2):375-380. PubMed ID: 27878631
[TBL] [Abstract][Full Text] [Related]
3. The effects of early intravenous immunoglobulin therapy for Kawasaki disease: The 22nd nationwide survey in Japan.
Kuwabara M; Yashiro M; Ae R; Yanagawa H; Nakamura Y
Int J Cardiol; 2018 Oct; 269():334-338. PubMed ID: 30049499
[TBL] [Abstract][Full Text] [Related]
4. Serum C-reactive protein levels in patients with Kawasaki disease: from the results of nation-wide surveys of Kawasaki disease in Japan.
Koyanagi H; Yanagawa H; Nakamura Y; Yashiro M
Acta Paediatr; 1997 Jun; 86(6):613-9. PubMed ID: 9202797
[TBL] [Abstract][Full Text] [Related]
5. Lower level of serum potassium and higher level of C-reactive protein as an independent risk factor for giant aneurysms in Kawasaki disease.
Koyanagi H; Nakamura Y; Yanagawa H
Acta Paediatr; 1998 Jan; 87(1):32-6. PubMed ID: 9510444
[TBL] [Abstract][Full Text] [Related]
6. Case-control study of giant coronary aneurysms due to Kawasaki disease: the 19th nationwide survey.
Sudo D; Monobe Y; Yashiro M; Sadakane A; Uehara R; Nakamura Y
Pediatr Int; 2010 Oct; 52(5):790-4. PubMed ID: 20487371
[TBL] [Abstract][Full Text] [Related]
7. Cardiac sequelae of Kawasaki disease among recurrent cases.
Nakamura Y; Yanagawa H; Ojima T; Kawasaki T; Kato H
Arch Dis Child; 1998 Feb; 78(2):163-5. PubMed ID: 9579161
[TBL] [Abstract][Full Text] [Related]
8. Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease.
Honkanen VE; McCrindle BW; Laxer RM; Feldman BM; Schneider R; Silverman ED
Pediatr Cardiol; 2003; 24(2):122-6. PubMed ID: 12457252
[TBL] [Abstract][Full Text] [Related]
9. Incidence of Kawasaki disease in Japan: the nationwide surveys of 1999-2002.
Yanagawa H; Nakamura Y; Yashiro M; Uehara R; Oki I; Kayaba K
Pediatr Int; 2006 Aug; 48(4):356-61. PubMed ID: 16911079
[TBL] [Abstract][Full Text] [Related]
10. Cardiac sequelae of Kawasaki disease in Japan: statistical analysis.
Nakamura Y; Fujita Y; Nagai M; Yanagawa H; Imada Y; Okawa S; Kawasaki T; Kato H
Pediatrics; 1991 Dec; 88(6):1144-7. PubMed ID: 1720235
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal presentation of Kawasaki disease: A red flag for severe disease?
Fabi M; Corinaldesi E; Pierantoni L; Mazzoni E; Landini C; Bigucci B; Ancora G; Malaigia L; Bodnar T; Di Fazzio G; Lami F; Valletta E; Cicero C; Biasucci G; Iughetti L; Marchetti F; Sogno Valin P; Amarri S; Brusa S; Sprocati M; Maggiore G; Dormi A; Lanzoni P; Donti A; Lanari M
PLoS One; 2018; 13(9):e0202658. PubMed ID: 30180185
[TBL] [Abstract][Full Text] [Related]
12. Six principal symptoms and coronary artery sequelae in Kawasaki disease.
Nakamura Y; Yashiro M; Sadakane A; Aoyama Y; Oki I; Uehara R; Yanagawa H
Pediatr Int; 2009 Oct; 51(5):705-8. PubMed ID: 19419505
[TBL] [Abstract][Full Text] [Related]
13. Relationship between ocular manifestations, laboratory findings, echocardiographic findings, and intravenous immunoglobulin resistance in Kawasaki disease.
Jari M; Esmaeili H
Pediatr Rheumatol Online J; 2024 May; 22(1):50. PubMed ID: 38693550
[TBL] [Abstract][Full Text] [Related]
14. Erythrocyte sedimentation rate and C-reactive protein discrepancy and high prevalence of coronary artery abnormalities in Kawasaki disease.
Anderson MS; Burns J; Treadwell TA; Pietra BA; Glodé MP
Pediatr Infect Dis J; 2001 Jul; 20(7):698-702. PubMed ID: 11465843
[TBL] [Abstract][Full Text] [Related]
15. Effects of gamma-globulin on the cardiac sequelae of Kawasaki disease.
Yanagawa H; Tuohong Z; Oki I; Nakamura Y; Yashiro M; Ojima T; Tanihara S
Pediatr Cardiol; 1999; 20(4):248-51. PubMed ID: 10368448
[TBL] [Abstract][Full Text] [Related]
16. Use of laboratory data to identify risk factors of giant coronary aneurysms due to Kawasaki disease.
Nakamura Y; Yashiro M; Uehara R; Watanabe M; Tajimi M; Oki I; Ojima T; Sonobe T; Yanagawa H
Pediatr Int; 2004 Feb; 46(1):33-8. PubMed ID: 15043662
[TBL] [Abstract][Full Text] [Related]
17. Factors related to cardiac sequelae of Kawasaki disease.
Zhang T; Yanagawa H; Oki I; Nakamura Y; Yashiro M; Ojima T; Tanihara S
Eur J Pediatr; 1999 Sep; 158(9):694-7. PubMed ID: 10485297
[TBL] [Abstract][Full Text] [Related]
18. Relationship between mean platelet volume-to-lymphocyte ratio and coronary artery abnormalities in Kawasaki disease.
Bozlu G; Karpuz D; Hallioglu O; Unal S; Kuyucu N
Cardiol Young; 2018 Jun; 28(6):832-836. PubMed ID: 29656728
[TBL] [Abstract][Full Text] [Related]
19. Case-control study of giant coronary aneurysms due to Kawasaki disease.
Nakamura Y; Yashiro M; Uehara R; Watanabe M; Tajimi M; Oki I; Ojima T; Yanagawa H
Pediatr Int; 2003 Aug; 45(4):410-3. PubMed ID: 12911476
[TBL] [Abstract][Full Text] [Related]
20. Prediction of responsiveness or non-responsiveness to treatment of acute Kawasaki disease using 1 gram per kilogram of immunoglobulin--an effective and cost-saving schedule of therapy.
Ichihashi K; Shiraishi H; Momoi M
Cardiol Young; 2009 Jun; 19(3):224-7. PubMed ID: 19272202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
